期刊文献+

羧甲基壳聚糖水凝胶制备及在药物控释中的应用 被引量:12

The Preparation of CMCS-GA and Its Application in Drug Release-Controlled Systems
在线阅读 下载PDF
导出
摘要 研究羧甲基壳聚糖水凝胶(CMCS-GA)对阿司匹林的吸附性能及其在药物控释系统中的应用。以羧甲基壳聚糖作为骨架材料,采用戊二醛交联法制备CMCS-GA,进而制备阿司匹林载药凝胶。测定凝胶在人工肠液中的溶胀动力学特点,观察载药凝胶在人工肠液中的体外释放行为。在pH=7.4的人工肠液中CMCS-GA 2 h达最大溶胀度1.38。CMCS-GA的载药量为4.6 mg/g,凝胶在人工肠液中96 h的累积释放度为99.91%,具有优良的缓释性能,药物的体外释放模型符合一级动力学方程。 The object of this study was to evaluate the adsorption capability of CMCS-GA to aspirin and its application in drug release-controlled systems. CMCS-GA based on CMS were prepared by cross-linking with glutaraldehyde, then aspirin entrapped hydrogel was prepared by the adsorption effect of CMCS-GA to aspirin. The swelling characteristics and the release behaviors of aspirin entrapped hydrogel in simulated intestinal juice (pH = 7.4) have been studied respectively. CMCS-GA in the simulated intestinal juice (pH = 7.4) reached the maximum swelling degree 1.38 in 2 h. The adsorbing capacity of aspirin by CMCS-GA was 4.6 mg/g, the cumulated release rate of aspirin entrapped hydrogel in the simulated intestinal juice (pH = 7.4) for 96h was 99.91%, which indicated the excellent release-controlled capability of the aspirin entrapped hydrogel. The results also showed that the release profile of aspirin from hydrogel followed first order kinetic equations.
出处 《中国海洋大学学报(自然科学版)》 CAS CSCD 北大核心 2007年第3期503-506,共4页 Periodical of Ocean University of China
关键词 壳聚糖 戊二醛 缓释凝胶 体外释放度 chitosan GA release-controlled hydrogel drug releasing in vitro
作者简介 徐甲坤(1984-),男,硕士生。E—mail:chenfeng858652@163.com 通讯作者:E—mail:bcfeng@ouc.edu.cn
  • 相关文献

参考文献11

  • 1Wang L S,Khor E,Lim L Y.Chitosan-alginate-CaCl2 system for membrane coat application[J].J Pharm Sci,2001,90(8):1134-1142.
  • 2Jung K L,Soo U,Jung H K,et al.Modification of chitosan to improve its hypocholesterolemic capacity[J].Biosci Biotechnol Biochem,1999,63(5):833-838.
  • 3Chen S C,Wu Y C,Mi F L,et al.A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery[J].J Contr Rel,2004,96(3):285-300.
  • 4Thanou M,Nihot M T,Jansen M,et al.Mono-N-carboxymethyl chitosan (MCC),a polyampholytic chitosan derivative,enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo[J].J Pharm Sci,2001,90(1):38-46.
  • 5屠锡德 毛凤斐 李娟.阿司匹林缓释片的研制及体内药物动力学研究.南京药学院学报,1986,17(2):107-111.
  • 6杨红梅,陈旭,赵坤杰.阿司匹林壳聚糖缓释片的体外释放度研究[J].河南大学学报(医学版),2005,24(1):37-38. 被引量:11
  • 7唐振兴,钱俊青,石陆娥.羧甲基壳聚糖制备工艺的研究[J].化工技术与开发,2004,33(2):4-7. 被引量:10
  • 8陈凌云,杜予民,肖玲,覃彩芹.羧甲基壳聚糖的取代度及保湿性[J].应用化学,2001,18(1):5-8. 被引量:93
  • 9Pham le Dung,Michel Milas,Marguerite Rinaudo,et al.Water soluble derivatives obtained by controlled chemical modifications of chitosan[J].Carbohydrate Polymers,1994,24:209-214.
  • 10Keisuke Kurita,J unji Amemiya,Tomonori Mori,et al.Combshaped Chitosan Derivatives having Oligo (ethylene glycol) side chains[J].Polymer Bulletin,1999,42:387-393.

二级参考文献24

共引文献115

同被引文献152

引证文献12

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部